Preview

Вестник дерматологии и венерологии

Расширенный поиск

Заболевания кожи, ассоциированные с ожирением

https://doi.org/10.25208/0042-4609-2016-0-6-20-26

Полный текст:

Аннотация

Ожирение является серьезной медицинской проблемой во всем мире. В последние годы отмечается рост числа больных с ожирением. В обзоре литературы представлены данные о влиянии ожирения на кожу. Оно связано с развитием ряда дерматологических заболеваний, в том числе acantosis nigricans, акрохордонов, фолликулярного гиперкератоза, инфекционных заболеваний кожи. На фоне ожирения ухудшается течение псориаза. Обсуждается связь ожирения и атопического дерматита.

Об авторах

И. А. Горланов
ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России
Россия


Д. В. Заславский
ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России
Россия


Л. М. Леина
ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России
Россия


И. Р. Милявская
ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России
Россия


Список литературы

1. Shipman A.R., Millington G.W.M. Obesity and the skin. Br J Dermatol 2011: 165 (4): 743-750.

2. Tobin A., Ahern T., Rogers S. et al. The dermatological consequences of obesity. Int J dermatol 2013; 52; 927-932.

3. Lau K., Hoger P.H. Skin diseases associated with obesity in children. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2013; 56 (4): 539-42.

4. Scheinfeld N.S. Obesity and dermatology. Clin. Dermatol. 2004; 22: 303-9.

5. Yosipovitch G., DeVore A., Dawn A. Obesity and skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol 2007; 56 (6): 901-916.

6. Millington G.W.M. Obesity, genetics and the skin. Clin Exp Dermatol 2013; 38 (1): 50-56.

7. Loftier H., Aramaki J.U., Effendy I. The influence of body mass index on skin susceptibility to sodium lauryl sulphate. Skin Res Technol 2002; 8: 19-22.

8. Guida B., Nino M., Perrino N.R. et al. The impact of obesity on skin disease and epidermal permeability barrier status. J Eur Acad Dermatol Venerol 2010; 24: 191-195.

9. Nino M., Franzese A., Ruggiero Perrino N., Balato N. The effect of obesity on skin disease and epidermal permeability barrier status in children. Pediatr Dermatol 2012; 29 (5): 567-570.

10. Garcia-Hidalgo L., Orozco-Torete R., Gonzalez-Barranco J. et al. Dermatoses in 156 obese adults. Obes Res 1999; 7: 299-302.

11. Al-Mutairi N. Associated cutaneous diseases in obese adult patients: a prospective study from a skin referral care center. Med Princ Pract 2011; 20 (3): 248-52.

12. Boza J.C., Trindade E.N., Peruzzo J., Rech L., Cestari T.F. Skin manifectations of obesity: a comparative study. J Eur Acad Dermatol Venereol 2012; 26: 1220-1223.

13. Hercogova J., Ricceri F., Tripo L., Lotti T., Prignano F. Psoriasis and body mass index. Dermatol Ther 2010; 23: 152-154.

14. Wolk K., Mallbris L., Larsson P., Rosenblad A., Vingard E., Stahle M. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm Venereol 2009; 89: 492-497.

15. Birtane M., Tuna H. The evaluation of plantar pressure distribution in obese and non-obese adults. Clin Biomech 2004; 19: 1055-9.

16. Mann R.A., Mann J.A. Keratotic disorders of the plantar skin. Instr Course Lect 2004; 53: 287-302.

17. Garcia-Hidalgo L. Dermatological complications of obesity. Am J Clin Dermatol 2002; 3: 497-506.

18. Hud J.A. Jr, Cohen J.B., Wagner J.M., Cruz P.D. Jr. Prevalence and significance of acantosis nigricans in an adult obese population. Arch Dermatol 1992; 128: 941-4.

19. Torley D., Bellus G.A., Munro C.S. Genes growth factors and acantosis nigricans. Br J Dermatol 2002; 147; 1096.

20. Дерматология Фицпатрика в клинической практике. Вольф К., Голдсмит Л.А., Кац С.И., Джилкрест Б.А. и др. Пер. с англ. М; 2013.

21. Rogalski C., Haustein U.F., Glander H.J., Paasch U. Extensive striae distensae as a result of topical corticosteroid therapy in psoriasis vulgaris. Acta Derm Venereol 2003; 83: 54-5.

22. Hsu H.S., Chen W., Chen S.C., Ko F.D. Colored striae in obese children and adolescents. Zhong-hua Min Guo. Xiao Er Ke Yi Xue Hui Za Zhi 1996; 37: 349-52.

23. Angeli A., Boccuzzi G., Frajria R., Bisbocci D. Adrenal gland function test in the differential diagnosis of sthenic obesity with pink striae. Folia Endocrinol. 1970; 23: 566-78.

24. Kang S. Topical tretinoin therapy for management of early striae. J Am Acad Dermatol 1998; 39 (Suppl): S90-2.

25. Yosipovitch G., Mevorah B., Mashiach J., Chan Y.H., David M. High body mass index, dry scaly leg skin and atopic conditions are highly associated with keratosis pilaris. Dermatology 2000; 201; 34-6.

26. Gupta A.K., Ryder J.E., Lynch L.E., Tavakkol A. The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence. J Drugs Dermatol 2005; 4: 302-8.

27. Herron M.D., Hinckley M., Hoffman M.S., Papenfuss J., Hansen C.B., Callis K.P. et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 14: 1527-34.

28. Bremer S., Van Voorhess A.S., Hsu S., Korman N.J. at all. Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2010; 63 (6): 1058-69.

29. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986; 172: 298-304.

30. Sakai R., Matsui S., Fukushima M., Yasuda H., Miyauchi H., Miyachi Y. Prognostic factor analysis for plaque psoriasis. Dermatology 2005; 211: 103-6.

31. Setty A.R., Curhan G., Choi H.K. Obesity, waist circumference, weight change and the risk of psoriasis in women: Nurses Health Study II. Arch Intern Med 2007; 167: 1670-5.

32. Kumar S., Han J., Li T., Qureshi A.A. Obesity, waist circumference, weight change and the risk of psoriasis in US women. J Eur Acad Dermatology Venereol 2013; 27 (10): 1293-1298.

33. Paller A.S., Mercy K., Kwasny M.J., Choon S.E. and all. Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional stu dy. JAMA Dermatol 2013; 149 (2): 166-76.

34. Soltani-Arabshahi R, Wong B, Feny BJ et al. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol 2010; 146: 721-6.

35. Mahe E., MacCari F., Beauchet A. et al. Childhood-onset psoriasis: Association with future cardiovascular and metabolic comorbidities. Br J Dermatol 2013; 169 (4): 889-895.

36. Shapiro J., Cohen D., David M. et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007; 56: 629-34.

37. Cohen A., Gilutz H., Henkin Y. et al. Psoriasis and the Metabolic Syndrome. Acta Derm Venereol 2007; 87 (6): 506-509.

38. Koebnick C., Black M.N., Smith N., Der-Sarkissian J.K. et al. The association of psoriasis and elevated blood lipids in overweight and obese children. J Pediatr 2011; 159 (4): 577-83.

39. Perez-Perez I., Allegue F., Caeiro J.I. et al. Severe psoriasis, morbid obesity and bariatric surgery. Clin Exp Dermatol 2009; 34: 421-2.

40. Song A.Y., Rubin J.P., Thomas V. et al. Body image and quality of life in post massive weight loss body contouring patients. Obesity 2006; 14: 1626-36.

41. Rucevic I., Perl A., Barisic-Drusko V., AdamPerl M. The role of the low energy diet in psoriasis vulgaris treatment. Coll Antropol 2003; 27 (Suppl. 1): 41-8.

42. Higa-Sansone G., Szomstein S., Soto F., Brasecsco O., Cohen C., Rosenthal R.J. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004; 14: 1132-4.

43. Jensen P., Zachariae C., Christensen R. et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Derm Venereol 2014; 94 (6): 691-694.

44. Ковалева О.А., Амбросова Т.Н., Ащеулова Т.В. Адипокины: биологические, патофизиологические и метаболические эффекты. Внутренняя медицина 2009; 3: 15-23.

45. Gerdes S., Rostami-Yazdi M., Mrowietz U. Adipokines and psoriasis. Exp Dermatol 2011; 20 (2): 81-87.

46. Ceman A.A., Bozkurt S., Sav A. et al. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol 2008; 159: 820-6.

47. Johnston A., Arnadottir S., Gudjonsson J.E. et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol 2008; 159: 342-50.

48. Coimbra S., Oliveira H., Reis F. et al. Circulating adipokine levels in Portugese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol 2010; 24: 1386-94.

49. Chen Y., Rennie D., Cormier Y., Dosman J. Association between obesity and atopy in adults. Int Arch Allergy Immunol 2010; 153 (4): 372-377.

50. Silverberg J.I., Silverberg N.B., Lee-Wong M. Association between atopic dermatitis and obesity in adulthood. Br J Dermatol 2012; 166 (3): 498-504.

51. Baruwa P., Sarmah K.R. Obesity and asthma. Lung India 2013; 30 (1): 38-46.

52. Abdul Wahab A., Maarafiya M.M., Soliman A., Younes NBM, Chandra P. Serum Leptin and Adiponectin Levels in Obese and Nonobese Asthmatic School Children in relation to Asthma Control. J Allergy 2013; 2013: 654104.

53. Agrawal A., Sood A., Linneberg A., Ghosh B. Mechanistic understanding of the effect of obesity on asthma and allergy. J Allergy 2013; 2013: 598904.

54. Silverberg J.I., Kleiman E., Lev-Tov H. at all. Association between obesity and atopic dermatitis in childhood: A case-control study. J Allergy Clin Immunol 2011; 127 (5): 1180-1186.

55. Silverberg J.I., Simpson E.L. Association between obesity and eczema prevalence, severity and poorer health in US adolescents. Dermat contact atopic Occup drug 2014; 25 (4): 172-81.

56. Hakala K., Stenius-Aarniala B., Sovijarvi A. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 2000; 118: 1315-21.

57. Murray C.S., Canoy D., Buchan I., Woodcock A. and all. Body mass index in young children and allergic disease: gender differences in a longitudinal study Clin Experimental Allergy 2010; 41: 78-85.

58. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-20.

59. Nagel G., Koenig W., Rapp K., Wabitsch M., Zoellner I., Weiland S.K. Associations of adipokines with asthma, rhinoconjunctivitis, and eczema in German schoolchildren. Pediatr Allergy Immunol 2009; 20: 81-8.

60. Guler N., Kirerlari E., Ones U., Tamay Z. and all. Leptin: does role in childhood astma? J allergy Clin Immunol 2004; 114 (2): 254-9.

61. Горланов И.А., Заславский Д.В., Милявская И.Р., Леина Л.М., Оловянишников О.В., Куликова С.Ю. Детская дерматовенерология: Учебник. М: Академия 2012; 352


Для цитирования:


Горланов И.А., Заславский Д.В., Леина Л.М., Милявская И.Р. Заболевания кожи, ассоциированные с ожирением. Вестник дерматологии и венерологии. 2016;(6):20-26. https://doi.org/10.25208/0042-4609-2016-0-6-20-26

For citation:


Gorlanov I.A., Zaslavskiy D.V., Leina L.M., Milyavskaya I.R. Obesity related skin disorders. Vestnik dermatologii i venerologii. 2016;(6):20-26. (In Russ.) https://doi.org/10.25208/0042-4609-2016-0-6-20-26

Просмотров: 211


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0042-4609 (Print)
ISSN 2313-6294 (Online)